West Michigan Life Sciences Sector on the Rise

BYLINE: HSA

Aug. 16, 2007 (BioHealth Investor delivered by Newstex) -- by Sara Calabro>Med Tech Sentinel>

>

According to The Grand Rapids Press, "West Michigan is on its way to attaining prominence in the life sciences

The paper, reporting this weekon a just released study on attracting investment to the region, says, "Grand Rapids' growing medical research capabilities, combined with Kalamazoo's heritage of producing drugs and medical devices, create a critical mass that can compete with such life sciences hotbeds as Boston, Seattle and

The study, which says $750 million to $1 billion will need to be spent upfront in order to attract $5 billion in new investment to West Michigan over the next 10 years, calls for attracting venture capital for later-stage research, drawing larger pools of engineering and life sciences talent, and expanding the region's global

Efforts are already underway to help nurture West Michigan's life sciences sector, of which roughly 200 companies are

In June, seven local companies -- MedBio, ATEK Medical, Autocam Medical, Emerald Medical Devices and Supplies, Inrad, Cascade Life Solutions and Surge Medical -- created the West Michigan Medical Device Consortium, a membership organization designed to assist small firms with product innovation, business collaboration, marketing and lean manufacturing technologies. The effort is backed by the West Michigan Science & Technology Initiative (WMSTI), a five-year-old partnership that was formed to grow and diversify the community economy by supporting the commercialization of science and

Kim Bode, WMSTI's marketing director, tells the Press that it's this very kind of coming together that makes West Michigan special. "What sets us apart from San Diego and Boston is the amount of collaboration," she

>

Med Tech Sentinel is a regular contributor to BioHealth _______________

>Newstex BIOI-0001-18954240


LOAD-DATE: August 16, 2007


LANGUAGE: ENGLISH


NOTES: The views expressed on blogs distributed by Newstex and its re-distributors ("Blogs via Newstex") are solely the author's and not necessarily the views of Newstex or its re-distributors. Posts from such authors are provided "AS IS", with no warranties, and confer no rights. The material and information provided in Blogs via Newstex are for general information only and should not, in any respect, be relied on as professional advice. No content on such Blogs via Newstex is "read and approved" before it is posted. Accordingly, neither Newstex nor its re-distributors make any claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained therein or linked to from such blogs, nor take responsibility for any aspect of such blog content. All content on Blogs via Newstex shall be construed as author-based content and commentary. Accordingly, no warranties or other guarantees will be offered as to the quality of the opinions, commentary or anything else offered on such Blogs via Newstex. Reader's comments reflect their individual opinion and their publication within Blogs via Newstex shall not infer or connote an endorsement by Newstex or its re-distributors of such reader's comments or views. Newstex and its re-distributors expressly reserve the right to delete posts and comments at its and their sole discretion.

Geography
Source
BioHealth Investor
Article Type
Staff News